Effects of immune checkpoint inhibitor associated endocrinopathies on cancer survival

Keyphrases

• Cancer-specific Survival 100%
• Endocrinopathy 100%
• Immune Checkpoint Inhibitors 100%
• Immune-related Adverse Events 100%
• Immune Checkpoint Inhibitor Treatment 23%
• Overall Survival 15%
• Survival Benefit 15%
• Time to Treatment Failure 15%
• IrAE 15%
• In Cancer 7%
• Single Center 7%
• Cancer Patients 7%
• Risk Factors 7%
• Advanced or Metastatic 7%
• Hormone Replacement Therapy 7%
• Cancer Prognosis 7%
• Retrospective Cohort Study 7%
• Metastatic Tumor 7%
• Thyroid Dysfunction 7%
• Overall Time 7%
• Treatment Cycle 7%
• Advanced Solid Tumors 7%

Medicine and Dentistry

• Cancer Survival 100%
• Endocrine Disease 100%
• Immune Checkpoint Inhibitor 100%
• Immune-Related Adverse Events 100%
• Time to Treatment 15%
• Overall Survival 15%
• Solid Malignant Neoplasm 7%
• Malignant Neoplasm 7%
• Thyroid Disease 7%
• Prospective Study 7%
• Cancer Prognosis 7%
• Retrospective Cohort Study 7%
• Hormone Substitution 7%

Pharmacology, Toxicology and Pharmaceutical Science

• Cancer Survival 100%
• Adverse Event 100%
• Endocrine Disease 100%
• Immune Checkpoint Inhibitor 100%
• Overall Survival 15%
• Malignant Neoplasm 7%
• Prospective Study 7%
• Solid Malignant Neoplasm 7%
• Thyroid Disease 7%
• Cohort Study 7%
• Cancer Prognosis 7%